Yu B - Search Results

1

A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer.

Geng F, Guo J, Guo QQ, Xie Y, Dong L, Zhou Y, Liu CL, Yu B, Wu H, Wu JX, Zhang HH, Kong W, Yu XH. Geng F, et al. Among authors: yu b, yu xh. Vaccine. 2019 Jul 18;37(31):4382-4391. doi: 10.1016/j.vaccine.2019.06.012. Epub 2019 Jun 12. Vaccine. 2019. PMID: 31202521

2

Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.

Yu B, Zhang Y, Zhan Y, Zha X, Wu Y, Zhang X, Dong Q, Kong W, Yu X. Yu B, et al. Among authors: yu x. Oncol Rep. 2011 Jul;26(1):255-64. doi: 10.3892/or.2011.1285. Epub 2011 Apr 28. Oncol Rep. 2011. PMID: 21573500

3

Chimeric hexon HVRs protein reflects partial function of adenovirus.

Yu B, Wang C, Dong J, Zhang M, Zhang H, Wu J, Wu Y, Kong W, Yu X. Yu B, et al. Among authors: yu x. Biochem Biophys Res Commun. 2012 May 4;421(2):170-6. doi: 10.1016/j.bbrc.2012.03.125. Epub 2012 Apr 3. Biochem Biophys Res Commun. 2012. PMID: 22490664

4

Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China.

Yu B, Zhou Y, Wu H, Wang Z, Zhan Y, Feng X, Geng R, Wu Y, Kong W, Yu X. Yu B, et al. Among authors: yu x. J Med Virol. 2012 Sep;84(9):1408-14. doi: 10.1002/jmv.23325. J Med Virol. 2012. PMID: 22825819

5

A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011.

Yu B, Wang Z, Dong J, Wang C, Gu L, Sun C, Kong W, Yu X. Yu B, et al. Among authors: yu x. Virol J. 2012 Nov 23;9:287. doi: 10.1186/1743-422X-9-287. Virol J. 2012. PMID: 23176136 Free PMC article.

6

Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera.

Yu B, Dong J, Wang C, Zhan Y, Zhang H, Wu J, Kong W, Yu X. Yu B, et al. Among authors: yu x. Virology. 2013 Mar 15;437(2):118-23. doi: 10.1016/j.virol.2012.12.014. Epub 2013 Jan 23. Virology. 2013. PMID: 23351390 Free article.

7

Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model.

Wang YQ, Zhang HH, Liu CL, Wu H, Wang P, Xia Q, Zhang LX, Li B, Wu JX, Yu B, Gu TJ, Yu XH, Kong W. Wang YQ, et al. Among authors: yu b, yu xh. Int Immunopharmacol. 2013 Sep;17(1):9-17. doi: 10.1016/j.intimp.2013.04.015. Epub 2013 Apr 25. Int Immunopharmacol. 2013. PMID: 23624214 Free article.

8

Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.

Wang X, Wang X, Zhang H, Lv M, Zuo T, Wu H, Wang J, Liu D, Wang C, Zhang J, Li X, Wu J, Yu B, Kong W, Yu X. Wang X, et al. Among authors: yu b, yu x. Retrovirology. 2013 Aug 29;10:94. doi: 10.1186/1742-4690-10-94. Retrovirology. 2013. PMID: 23988114 Free PMC article.

9

Sphere formation assay is not an effective method for cancer stem cell derivation and characterization from the Caco-2 colorectal cell line.

Wu H, Zhang H, Hu Y, Xia Q, Liu C, Li Y, Yu B, Gu T, Zhang X, Yu X, Kong W. Wu H, et al. Among authors: yu b, yu x. Curr Stem Cell Res Ther. 2014 Mar;9(2):82-8. doi: 10.2174/1574888x09666131217114927. Curr Stem Cell Res Ther. 2014. PMID: 24359140

10

Antitumor effect of adenoviral vector prime protein boost immunity targeting the MUC1 VNTRs.

Wang Y, Liu C, Xia Q, Wang P, Li B, Lu Z, Sun J, Wu H, Yu B, Wu J, Yu X, Kong W, Zhang H, Cong X. Wang Y, et al. Among authors: yu b, yu x. Oncol Rep. 2014 Mar;31(3):1437-44. doi: 10.3892/or.2013.2950. Epub 2013 Dec 30. Oncol Rep. 2014. PMID: 24378623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,493 results

Search Page

Filters